Form D · Biotechnology

Xenon Ophthalmics Inc

Jersey City, NJ · CIK 0001988832

Offering snapshot reported Oct 6, 2026 · SEC filing

Reported sold
$3.32M
Indefinite offering
Investors reported
20
Form D · investor count
Minimum accepted
$20K
Reported outside-investor minimum
First sale
Aug 15, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.66M$3.32MAug 22, 2023: $2,365,500.00Aug 22, 2023Aug 22, 2023: $2,365,500.00Oct 6, 2026: $3,315,004.00Oct 6, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,365,500 → $3,315,004
  • Reported investors16 → 20

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 6, 2026Amendment$3,315,004$949,504vs Aug 22, 202320SEC filing
Aug 22, 2023Initial$2,365,500No comparison16SEC filing
Aug 22, 2023Amendment$2,365,500$0vs Aug 22, 202316SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-490391

Source: Form D, filed Oct 6, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michelle De Fossett Director
Robert Gilligan Director
Zeshan Kahn Director, Executive
Zeshan Khan Director, Executive
David Singelyn Director
Bruce Stark Promoter
Steve Susanibar Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
525 Washington Blvd Suite 300
Jersey City, NJ, 07310
Phone: 9736194071